Hemoglobin Feed Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Bovine, Swine, Poultry, Shark, Synthetic, Others), By Application (Industrial, Commercial), Region and Competition, 2019-2029F
Published Date: February - 2025 | Publisher: MIR | No of Pages: 320 | Industry: Agriculture | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationHemoglobin Feed Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Bovine, Swine, Poultry, Shark, Synthetic, Others), By Application (Industrial, Commercial), Region and Competition, 2019-2029F
Forecast Period | 2025-2029 |
Market Size (2023) | USD 225.21 million |
Market Size (2029) | USD 284.61 million |
CAGR (2024-2029) | 4.15% |
Fastest Growing Segment | Swine |
Largest Market | North America |
Market Overview
Global Hemoglobin Feed Market was valued at USD 225.21 million in 2023 and is anticipated to grow with a CAGR of 4.15% through 2029.
The global hemoglobin feed market is a vital component of the animal nutrition industry, catering primarily to livestock and aquaculture sectors. Hemoglobin feed, derived from animal blood, serves as a rich source of essential nutrients, including proteins, amino acids, iron, and vitamins, making it a valuable dietary supplement for livestock and aquatic species.
Download Sample Ask for Discount Request Customization
Global Hemoglobin Feed Market has witnessed significant growth due to the rising demand for high-quality animal protein products, coupled with increasing awareness about the importance of balanced nutrition in animal husbandry practices. Key factors driving the growth of the global hemoglobin feed market include the expanding global population, growing consumer preference for protein-rich diets, and the rising demand for animal-based products such as meat, eggs, and dairy. The shift towards sustainable and environmentally friendly farming practices has spurred interest in alternative protein sources like hemoglobin feed, which can contribute to improved animal health and productivity while reducing environmental impact.
The advancements in processing technologies have led to the development of innovative hemoglobin feed products with enhanced nutritional profiles and improved digestibility, further fueling market growth. As the demand for high-quality animal protein continues to rise, the global hemoglobin feed market is expected to witness continued expansion, providing lucrative opportunities for manufacturers, suppliers, and stakeholders in the animal nutrition sector. Hemoglobin feed is a nutrient-rich supplement derived from animal blood, notably cattle or swine. It serves as a valuable source of proteins, amino acids, iron, and vitamins for livestock and aquaculture. Hemoglobin feed enhances animal health, growth, and productivity while ensuring balanced nutrition. With its high nutritional value, it contributes to the production of quality animal protein products such as meat, eggs, and dairy. Hemoglobin feed supports sustainable farming practices by offering an environmentally friendly alternative protein source. Its usage aligns with the growing demand for nutritious animal feed and underscores its significance in modern agriculture and aquaculture industries.
Key Market Drivers
Increasing Demand for Animal Protein
Global Hemoglobin Feed Market is witnessing a significant surge in demand, primarily driven by the escalating global appetite for animal protein. As the world's population continues to expand, particularly in emerging economies, there is a corresponding rise in the consumption of meat, eggs, dairy, and other animal-derived products. Hemoglobin feed emerges as a crucial component in addressing this demand, offering a nutrient-rich supplement derived from animal blood. Packed with essential nutrients such as proteins, amino acids, iron, and vitamins, hemoglobin feed plays a vital role in enhancing the health, growth, and productivity of livestock and aquatic species. Its nutritional profile aligns perfectly with the requirements for optimal animal nutrition, making it an indispensable component of modern animal feed formulations. The rising awareness of the importance of balanced animal nutrition among farmers and livestock producers further underscores the significance of hemoglobin feed in meeting the increasing demand for animal protein. By providing a concentrated source of essential nutrients, hemoglobin feed helps ensure that animals receive the necessary dietary requirements for healthy growth and development.
The increasing demand for animal protein is a key driver propelling the growth of the Global Hemoglobin Feed Market. As the need for protein-rich diets continues to rise, hemoglobin feed stands poised to play a pivotal role in supporting sustainable and efficient animal production systems worldwide.
Nutritional Benefits
Download Sample Ask for Discount Request Customization
Sustainable Farming Practices
Sustainable farming practices are increasingly becoming a focal point in agriculture, driving the Global Hemoglobin Feed Market towards a more environmentally conscious approach. Hemoglobin feed, derived from animal blood, aligns with the principles of sustainability by offering an environmentally friendly alternative protein source for livestock and aquaculture industries. As concerns about environmental degradation and resource depletion intensify, there is a growing demand for sustainable solutions that minimize the ecological footprint of agricultural activities. Hemoglobin feed contributes to sustainable farming practices in several ways. It utilizes co-products from the meat processing industry, thereby reducing waste and promoting resource efficiency. By repurposing animal blood, hemoglobin feed helps mitigate environmental pollution and landfill burden associated with organic waste disposal. Hemoglobin feed offers a nutrient-dense supplement that enhances animal health and productivity, reducing the need for excessive feed inputs and antibiotics. Healthy animals require fewer medical interventions and are more efficient in converting feed into meat, milk, or eggs. This, in turn, promotes resource efficiency and reduces the environmental impact of animal production systems. The hemoglobin feed supports sustainable intensification of livestock and aquaculture operations by optimizing nutrient utilization and minimizing nutrient losses to the environment. By providing essential nutrients in a concentrated form, hemoglobin feed enables farmers to achieve higher productivity levels with fewer inputs, thus reducing the ecological footprint per unit of output. The adoption of hemoglobin feed in animal nutrition programs represents a step towards more sustainable farming practices. As the demand for environmentally friendly agricultural solutions continues to grow, hemoglobin feed stands poised to play a pivotal role in driving sustainability across the Global Hemoglobin Feed Market.
Key Market Challenges
Regulatory Compliance
Regulatory compliance is a critical aspect of the Global Hemoglobin Feed Market, governing the production, distribution, and use of hemoglobin feed in animal nutrition. Due to its origin from animal blood, hemoglobin feed is subject to stringent regulations and oversight by regulatory authorities in different countries and regions. Compliance with these regulations is essential to ensure product safety, efficacy, and legal market access. One of the primary challenges in regulatory compliance for the hemoglobin feed market is the variability in regulatory requirements across different jurisdictions. Each country or region may have its own set of regulations governing the use of animal-derived ingredients in animal feed, as well as specific requirements for labeling, safety, and quality standards. Navigating this complex regulatory landscape requires a thorough understanding of local regulations and the ability to adapt to changing compliance requirements. The regulatory compliance often involves extensive documentation, testing, and certification processes, adding to the administrative burden and operational costs for manufacturers and suppliers of hemoglobin feed. Compliance with Good Manufacturing Practices (GMP), Hazard Analysis and Critical Control Points (HACCP), and other quality assurance standards is essential to ensure product safety and consistency. The regulatory compliance extends beyond national boundaries, particularly in the context of international trade. Exporting hemoglobin feed products to foreign markets requires adherence to import regulations, customs clearance procedures, and compliance with international trade agreements and standards.
Supply Chain Management
Download Sample Ask for Discount Request Customization
Key Market Trends
Rising Demand for Animal Protein
Segmental Insights
Source Insights
Based on
Application Insights
Based on application, commercial segment dominated the Global Hemoglobin Feed Market in 2023. This can be ascribed to the widespread adoption of hemoglobin feed in commercial livestock and aquaculture operations. Commercial enterprises prioritize efficient and cost-effective animal nutrition solutions to maximize production outcomes. Hemoglobin feed, with its high nutritional value and beneficial effects on animal health and growth, aligns with these objectives. Moreover, commercial producers often have larger-scale operations and greater purchasing power, enabling them to procure hemoglobin feed in bulk quantities. This, coupled with the increasing demand for animal protein, drives the dominance of the commercial segment in the Global Hemoglobin Feed Market.
Regional Insights
Asia Pacific region emerged as the fastest growing region in the global hemoglobin feed market, with China leading the way. The remarkable growth witnessed in this region can be attributed to the extensive production of plasma and hemoglobin powder within China. China plays a pivotal role as both a major producer and consumer of pig blood by-products, including plasma and hemoglobin feed. This growth is fueled by a surge in meat and seafood consumption, driven by factors such as increasing disposable income, urbanization, and population growth. The abundance of porcine blood generated in Chinese butcher shops contributes to the rising volume of hemoglobin powder.
Recent Developments
- In October 2023, Genexine and KGbio celebrated a significant achievement with the approval of their long-acting erythropoietin, Efepoetin alfa (GX-E4), by the Indonesian Ministry of Food and Drug Safety (BPOM). This approval was specifically for the treatment of chronic kidney disease-induced anemia in non-dialysis patients. The collaboration between Genexine and KGbio bore fruit with this milestone, marking the first market approval for a drug resulting from their joint research and development efforts. This development was not only a testament to their dedication to advancing medical treatment but also held promise for improving the lives of individuals affected by chronic kidney disease-induced anemia.
Key Market Players
- Abbott Laboratories, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- EKF Diagnostics Holdings plc
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific, Inc
- ACON Laboratories, Inc
- Bayer AG
- Read More Releated Report-
United Kingdom Plant Growth Regulators (PGRs) Market
Related Reports
- Forage Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Method (Physical M...
- Humic Based Biostimulants Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (...
- Controlled Release Fertilizers Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By T...
- Larvicide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Target (Mosquitoes, Flie...
- Pyrethroid Pesticide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Cyperme...
- Pyrethroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Bifenthrin, Delt...
Table of Content
Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. HEMOGLOBIN FEED MARKET, BY HEMOGLOBIN SOURCE (USD BILLION)
6.1. Bovine
6.2. Porcine
7. HEMOGLOBIN FEED MARKET, BY FEED TYPE (USD BILLION)
7.1. Hemoglobin Powder
7.2. Hemoglobin Concentrate
7.3. Hemoglobin Meal
8. HEMOGLOBIN FEED MARKET, BY LIVESTOCK (USD BILLION)
8.1. Poultry
8.2. Aquaculture
8.3. Swine
8.4. Ruminants
9. HEMOGLOBIN FEED MARKET, BY FORM (USD BILLION)
9.1. Dry
9.2. Liquid
9.3. Paste
10. HEMOGLOBIN FEED MARKET, BY FUNCTION (USD BILLION)
10.1. Iron Supplementation
10.2. Hematopoiesis Stimulation
11. HEMOGLOBIN FEED MARKET, BY REGIONAL (USD BILLION)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. UK
11.2.3. France
11.2.4. Russia
11.2.5. Italy
11.2.6. Spain
11.2.7. Rest of Europe
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Malaysia
11.3.6. Thailand
11.3.7. Indonesia
11.3.8. Rest of APAC
11.4. South America
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of South America
11.5. MEA
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of MEA
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market share Analysis
12.4. Major Growth Strategy in the Hemoglobin Feed Market
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Hemoglobin Feed Market
12.7. Key developments and growth strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales and Operating Income
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. Talecris Biotherapeutics, Inc.
13.1.1. Financial Overview
13.1.2. Products Offered
13.1.3. Key Developments
13.1.4. SWOT Analysis
13.1.5. Key Strategies
13.2. Octapharma AG
13.2.1. Financial Overview
13.2.2. Products Offered
13.2.3. Key Developments
13.2.4. SWOT Analysis
13.2.5. Key Strategies
13.3. CSL Behring AG
13.3.1. Financial Overview
13.3.2. Products Offered
13.3.3. Key Developments
13.3.4. SWOT Analysis
13.3.5. Key Strategies
13.4. Sangart, Inc.
13.4.1. Financial Overview
13.4.2. Products Offered
13.4.3. Key Developments
13.4.4. SWOT Analysis
13.4.5. Key Strategies
13.5. Biopure Corporation
13.5.1. Financial Overview
13.5.2. Products Offered
13.5.3. Key Developments
13.5.4. SWOT Analysis
13.5.5. Key Strategies
13.6. Kedrion S.p.A.
13.6.1. Financial Overview
13.6.2. Products Offered
13.6.3. Key Developments
13.6.4. SWOT Analysis
13.6.5. Key Strategies
13.7. Hemosol, Inc.
13.7.1. Financial Overview
13.7.2. Products Offered
13.7.3. Key Developments
13.7.4. SWOT Analysis
13.7.5. Key Strategies
13.8. Hemoglobin Oxygen Therapeutics, Inc.
13.8.1. Financial Overview
13.8.2. Products Offered
13.8.3. Key Developments
13.8.4. SWOT Analysis
13.8.5. Key Strategies
13.9. Fresenius Kabi AG
13.9.1. Financial Overview
13.9.2. Products Offered
13.9.3. Key Developments
13.9.4. SWOT Analysis
13.9.5. Key Strategies
13.10. Grifols, S.A.
13.10.1. Financial Overview
13.10.2. Products Offered
13.10.3. Key Developments
13.10.4. SWOT Analysis
13.10.5. Key Strategies
13.11. Samsung Bioepis Co., Ltd.
13.11.1. Financial Overview
13.11.2. Products Offered
13.11.3. Key Developments
13.11.4. SWOT Analysis
13.11.5. Key Strategies
13.12. Baxter Healthcare Corporation
13.12.1. Financial Overview
13.12.2. Products Offered
13.12.3. Key Developments
13.12.4. SWOT Analysis
13.12.5. Key Strategies
13.13. Shire Plc.
13.13.1. Financial Overview
13.13.2. Products Offered
13.13.3. Key Developments
13.13.4. SWOT Analysis
13.13.5. Key Strategies
13.14. Pfizer, Inc.
13.14.1. Financial Overview
13.14.2. Products Offered
13.14.3. Key Developments
13.14.4. SWOT Analysis
13.14.5. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
List Tables Figures
List of Tables and Figures
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy